Last reviewed · How we verify

NCT03369132: FLASH

Efficacy of Natural Seawater Based Throat Spray in Acute Sore Throat Relief

Status unknown NA Last updated 22 December 2017
What this trial tests

NA trial testing Angiflash in Sore Throat in 360 participants. Status unknown.

Timeline
6 November 2017
Primary endpoint
31 May 2018
30 September 2018

Quick facts

Lead sponsorLaboratoire de la Mer
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment360
Start date6 November 2017
Primary completion31 May 2018
Estimated completion30 September 2018
Sites16 locations across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Laboratoire de la Mer

Who can join

18 and older, any sex, with Sore Throat. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, randomized, double-blind, placebo-controlled, multicentre clinical trial to assess the efficacy and tolerability of natural seawater based throat spray among adult patients with acute sore throat.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sore Throat

Currently open trials in the same condition.

Other Laboratoire de la Mer trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03369132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing